Advanced Reticulocyte Parameters in Hemolytic Anemias
Advanced Reticulocyte Parameters as Biomarkers of Erythropoietic Response in Hemolytic Anemias
This cross-sectional study aims to evaluate advanced reticulocyte parameters in patients with thalassemia and sickle cell disease compared with healthy controls.
研究概览
详细说明
Hemolytic anemia is characterized by premature destruction of red blood cells. Reticulocytes are immature red blood cells released from the bone marrow, and their assessment reflects erythropoietic activity.
Modern automated hematology analyzers provide advanced reticulocyte parameters including reticulocyte percentage, absolute reticulocyte count, reticulocytes with low, medium and high ribonucleic acid (RNA) content, immature reticulocyte fraction, mean reticulocyte volume, and reticulocyte hemoglobin content.
This observational study will measure these advanced reticulocyte parameters in adult patients with beta-thalassemia, patients with sickle cell disease, and healthy controls.
研究类型
注册 (估计的)
联系人和位置
学习联系方式
- 姓名:Kholoud A Ahmed, Resident
- 电话号码:01553673654
- 邮箱:khloud.18313224@med.aun.edu.eg
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
取样方法
研究人群
Patients with beta-thalassemia, patients with sickle cell disease, and healthy controls attending Assiut University Hospitals.
描述
Inclusion Criteria:
- - Patients with beta-thalassemia
- Patients with sickle cell disease
- Healthy controls
- Written informed consent
Exclusion Criteria:
- - Other types of anemia
- Recent blood transfusion
学习计划
研究是如何设计的?
设计细节
- 观测模型:CASE_CONTROL
- 时间观点:CROSS_SECTIONAL
队列和干预
团体/队列 |
|---|
|
Thalassemia Patients
Patients diagnosed with beta-thalassemia. |
|
Sickle Cell Disease Patients
Patients diagnosed with sickle cell disease. |
|
Healthy Controls
Apparently healthy individuals without anemia or hemoglobinopathy. |
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Immature reticulocyte fraction
大体时间:Baseline
|
Mean immature reticulocyte fraction measured by automated hematology analyzer (percentage). |
Baseline
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Absolute reticulocyte count
大体时间:Baseline
|
Mean absolute reticulocyte count measured by automated hematology analyzer (cells per microliter). |
Baseline
|
|
Reticulocyte percentage
大体时间:Baseline
|
Mean reticulocyte percentage measured by automated hematology analyzer. |
Baseline
|
|
Reticulocyte hemoglobin content
大体时间:Baseline
|
Mean reticulocyte hemoglobin content measured by automated hematology analyzer (picograms). |
Baseline
|
|
Mean reticulocyte volume
大体时间:Baseline
|
Mean reticulocyte volume measured by automated hematology analyzer (femtoliters). |
Baseline
|
合作者和调查者
调查人员
- 学习椅:Hisham A Abdel-Baset, prof、Clinical pathology Department, Assiut University Hospitals
研究记录日期
研究主要日期
学习开始 (估计的)
初级完成 (估计的)
研究完成 (估计的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
与本研究相关的术语
其他相关的 MeSH 术语
其他研究编号
- Retic-Params-HA-Assiut-2026
计划个人参与者数据 (IPD)
计划共享个人参与者数据 (IPD)?
药物和器械信息、研究文件
研究美国 FDA 监管的药品
研究美国 FDA 监管的设备产品
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.